Journal of Cardiac Failure
Volume 9, Issue 1 , Pages 69-75, February 2003

Cardiac contractility modulation with nonexcitatory electric signals improves left ventricular function in dogs with chronic heart failure☆☆

Detroit, Michigan

Mount Laurel, New Jersey

From the *Departments of Medicine, Division of Cardiovascular Medicine, Henry Ford Heart and Vascular Institute, Henry Ford Health System, Detroit, Michigan; and Impulse Dynamics, Mount Laurel, New Jersey

Received 31 May 2002; received in revised form 6 November 2002 and 14 November 2002

Abstract 

Background: Nonexcitatory electrical, signals termed cardiac contractility modulation (CCM) have been shown to improve contractile force of isolated papillary muscles. In this study, we examined the effects of CCM signal delivery on left ventricular function in dogs with chronic heart failure (HF). Methods and Results: Chronic HF (ejection fraction ≤35%) was produced in 7 dogs by intracoronary microembolizations. The CCM signal was delivered during the absolute refractory period using a lead implanted in the anterior coronary vein. A right ventricular and an atrial lead were implanted and used for timing of the CCM signal delivery. Hemodynamic measurements were made at baseline and at 1, 2, 3, 4, 5, and 6 hours after initiating CCM signal delivery. Ejection fraction increased from 31 ± 1% at baseline to 41 ± 1% at 1 hour (P < .05), 42 ± 1% at 3 hours (P < .05), and 44 ± 2% at 6 hours (P < .05). Similarly, stroke volume increased from 26 ± 2 mL to 31 ± 3 mL at 1 hour (P < .05), 33 ± 3 mL at 3 hours (P < .05), and 34 ± 3 mL at 6 hours (P < .05). There were no significant changes compared to baseline in ejection fraction or stroke volume in 5 HF control dogs studied for up to 4 hours. Conclusion: In dogs with HF, CCM signal delivery for 6 hours elicited marked improvement in LV function. This novel approach may represent a useful adjunctive therapy for the treatment of patients with HF.

Keywords:  Hemodynamics, absolute refractory period, ejection fraction

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Doctors Haddad, Mika, and Ben-Haim are employees/officers of Impulse Dynamics, the manufacturer of this technology.

☆☆ Supported, in part, by grants from Impulse Dynamics and the National Heart, Lung, and Blood Institute, HL49090-07.

 Reprint requests: Hani N. Sabbah, PhD, Director, Cardiovascular Research, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, MI 48202.

PII: S1071-9164(02)25408-1

doi:10.1054/jcaf.2003.8

Journal of Cardiac Failure
Volume 9, Issue 1 , Pages 69-75, February 2003